Status:
COMPLETED
5-fluorouracil for Treatment of Stable Vitiligo
Lead Sponsor:
Al-Azhar University
Conditions:
Vitiligo
Eligibility:
All Genders
10+ years
Phase:
NA
Brief Summary
Vitiligo, a significant dermatologic challenge affecting 0.5 to 2% of the global population. Despite various existing medical approaches, current vitiligo treatments are still far from optimal.
Detailed Description
Vtiligo, a significant dermatologic challenge affecting 0.5 to 2% of the global population. Despite various existing medical approaches, current vitiligo treatments are still far from optimal. 5FU is ...
Eligibility Criteria
Inclusion
- Patients with stable vitlligo
Exclusion
- patients under the age of 10 years.
- Individuals with a history of the Koebner phenomenon, a tendency for keloid or hypertrophic scarring
- Pregnancy.
- Recent isotretinoin therapy within the last 6 months.
Key Trial Info
Start Date :
January 23 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 15 2024
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06209138
Start Date
January 23 2024
End Date
April 15 2024
Last Update
April 17 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Al-Azhar University
Asyut, No State, Egypt